The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Change in HER2 status after neoadjuvant chemotherapy (NAC) with trastuzumab and pertuzumab (HP) in patients with HER2-positive early-stage breast cancer.
 
Emanuela Ferraro
No Relationships to Disclose
 
Pedram Razavi
Honoraria - Epic Sciences; Inivata
Consulting or Advisory Role - AstraZeneca; Epic Sciences; Foundation Medicine; Inivata; Natera; Novartis; Tempus
Research Funding - Archer (Inst); Epic Sciences (Inst); GRAIL (Inst); Illumina (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Epic Sciences; Guardant Health
 
Sarat Chandarlapaty
Consulting or Advisory Role - BMS; Lilly; Novartis; Paige.ai; Sanofi; Sermonix Pharmaceuticals; Totus Medicines
Research Funding - Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Paige.ai (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patents for (1) targeting mutant ER with ER PROTACS and (2) detecting genomic and histologic alterations in breast cancer using machine learning algorithms. (Inst)
Travel, Accommodations, Expenses - BMS
 
Shanu Modi
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Macrogenics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Genentech; Seagen
Research Funding - Daiichi Sankyo; Novartis; Roche/Genentech; Seagen; Synta
Travel, Accommodations, Expenses - Daiichi Sankyo; Genentech
 
Hannah Yong Wen
No Relationships to Disclose
 
Edi Brogi
No Relationships to Disclose
 
Larry Norton
Stock and Other Ownership Interests - Codagenix; Martell diagnostic; Medaptive Health; Samus Therapeutics
Honoraria - Agenus; ASCO; Codagenix; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Context Therapeutics; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sarah Lawrence College; Sermonix Pharmaceuticals
Consulting or Advisory Role - Agenus; ASCO; Breast Cancer Research Program; Codagenix; Cold Spring Harbor Laboratory; Context Therapeutics; Hackensack University Medical Center; Martell diagnostic; Medaptive Health; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sermonix Pharmaceuticals
Travel, Accommodations, Expenses - AACR; Breast Cancer Research Foundation; Breast Cancer Research Program; Cold Spring Harbor Laboratory; Oncology Pioneers
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst)
Other Relationship - Clinical Care Options; Invitae (Inst); Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Epic Sciences; Merck; Pfizer
 
Chau T. Dang
Honoraria - eviCore healthcare; Puma Biotechnology
Consulting or Advisory Role - eviCore healthcare; Puma Biotechnology
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)